Cargando…
Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation
BACKGROUND: Because of the supply shortage for homologous vein allografts, we previously used ringed Gore-Tex vascular grafts for middle hepatic vein (MHV) reconstruction in living donor liver transplantation. However, owing to the subsequent unavailability of ringed Gore-Tex grafts, we replaced the...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936210/ https://www.ncbi.nlm.nih.gov/pubmed/31844037 http://dx.doi.org/10.12659/AOT.919780 |
_version_ | 1783483701822226432 |
---|---|
author | Park, Gil-Chun Hwang, Shin Ha, Tae-Yong Song, Gi-Won Jung, Dong-Hwan Ahn, Chul-Soo Moon, Deok-Bog Kim, Ki-Hun Yoon, Young-In Cho, Hui-Dong Kwon, Jae-Hyun Chung, Yong-Kyu Kang, Sang-Hyun Jung, I-Ji Choi, Jin-Uk Lee, Sung-Gyu |
author_facet | Park, Gil-Chun Hwang, Shin Ha, Tae-Yong Song, Gi-Won Jung, Dong-Hwan Ahn, Chul-Soo Moon, Deok-Bog Kim, Ki-Hun Yoon, Young-In Cho, Hui-Dong Kwon, Jae-Hyun Chung, Yong-Kyu Kang, Sang-Hyun Jung, I-Ji Choi, Jin-Uk Lee, Sung-Gyu |
author_sort | Park, Gil-Chun |
collection | PubMed |
description | BACKGROUND: Because of the supply shortage for homologous vein allografts, we previously used ringed Gore-Tex vascular grafts for middle hepatic vein (MHV) reconstruction in living donor liver transplantation. However, owing to the subsequent unavailability of ringed Gore-Tex grafts, we replaced them with Hemashield vascular grafts. This study aimed to compare the patency of Hemashield grafts with that of ringed Gore-Tex grafts. MATERIAL/METHODS: This was a retrospective double-arm study between the study group that used Hemashield grafts (n=63) and the historical control group that used ringed Gore-Tex grafts (n=126). RESULTS: In the Gore-Tex and Hemashield groups, mean age was 53.1±6.2 and 54.3±10.4 years; model for end-stage liver disease score was 16.5±8.3 and 17.5±9.9; and graft-recipient weight ratio was 1.11±0.23 and 1.12±0.25, respectively. In the Gore-Tex graft group, V5 reconstruction was done in single (n=107, 84.9%), double (n=17, 13.5%), and none (n=2, 1.6%). V8 reconstruction was done in single (n=95, 75.4%), double (n=1, 0.8%), and none (n=30, 23.8%). In the Hemashield group, V5 reconstruction was done in single (n=43, 68.3%), double (n=19, 30.2%), and triple (n=1, 1.6%). V8 reconstruction was done in single (n=45, 71.4%), double (n=9, 14.3%), and none (n=9, 14.3%). One-year conduit patency rates in the Gore-Tex and Hemashield groups were 54.8% and 71.6%, respectively (p=0.048). CONCLUSIONS: MHV reconstruction using Hemashield vascular grafts demonstrated higher short-term patency rates than those associated with ringed Gore-Tex vascular grafts. We suggest that the Hemashield vascular graft is one of the best prosthetic materials for MHV reconstruction. |
format | Online Article Text |
id | pubmed-6936210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69362102020-01-06 Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation Park, Gil-Chun Hwang, Shin Ha, Tae-Yong Song, Gi-Won Jung, Dong-Hwan Ahn, Chul-Soo Moon, Deok-Bog Kim, Ki-Hun Yoon, Young-In Cho, Hui-Dong Kwon, Jae-Hyun Chung, Yong-Kyu Kang, Sang-Hyun Jung, I-Ji Choi, Jin-Uk Lee, Sung-Gyu Ann Transplant Original Paper BACKGROUND: Because of the supply shortage for homologous vein allografts, we previously used ringed Gore-Tex vascular grafts for middle hepatic vein (MHV) reconstruction in living donor liver transplantation. However, owing to the subsequent unavailability of ringed Gore-Tex grafts, we replaced them with Hemashield vascular grafts. This study aimed to compare the patency of Hemashield grafts with that of ringed Gore-Tex grafts. MATERIAL/METHODS: This was a retrospective double-arm study between the study group that used Hemashield grafts (n=63) and the historical control group that used ringed Gore-Tex grafts (n=126). RESULTS: In the Gore-Tex and Hemashield groups, mean age was 53.1±6.2 and 54.3±10.4 years; model for end-stage liver disease score was 16.5±8.3 and 17.5±9.9; and graft-recipient weight ratio was 1.11±0.23 and 1.12±0.25, respectively. In the Gore-Tex graft group, V5 reconstruction was done in single (n=107, 84.9%), double (n=17, 13.5%), and none (n=2, 1.6%). V8 reconstruction was done in single (n=95, 75.4%), double (n=1, 0.8%), and none (n=30, 23.8%). In the Hemashield group, V5 reconstruction was done in single (n=43, 68.3%), double (n=19, 30.2%), and triple (n=1, 1.6%). V8 reconstruction was done in single (n=45, 71.4%), double (n=9, 14.3%), and none (n=9, 14.3%). One-year conduit patency rates in the Gore-Tex and Hemashield groups were 54.8% and 71.6%, respectively (p=0.048). CONCLUSIONS: MHV reconstruction using Hemashield vascular grafts demonstrated higher short-term patency rates than those associated with ringed Gore-Tex vascular grafts. We suggest that the Hemashield vascular graft is one of the best prosthetic materials for MHV reconstruction. International Scientific Literature, Inc. 2019-12-17 /pmc/articles/PMC6936210/ /pubmed/31844037 http://dx.doi.org/10.12659/AOT.919780 Text en © Ann Transplant, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Original Paper Park, Gil-Chun Hwang, Shin Ha, Tae-Yong Song, Gi-Won Jung, Dong-Hwan Ahn, Chul-Soo Moon, Deok-Bog Kim, Ki-Hun Yoon, Young-In Cho, Hui-Dong Kwon, Jae-Hyun Chung, Yong-Kyu Kang, Sang-Hyun Jung, I-Ji Choi, Jin-Uk Lee, Sung-Gyu Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation |
title | Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation |
title_full | Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation |
title_fullStr | Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation |
title_full_unstemmed | Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation |
title_short | Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation |
title_sort | hemashield vascular graft is a preferable prosthetic graft for middle hepatic vein reconstruction in living donor liver transplantation |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936210/ https://www.ncbi.nlm.nih.gov/pubmed/31844037 http://dx.doi.org/10.12659/AOT.919780 |
work_keys_str_mv | AT parkgilchun hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT hwangshin hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT hataeyong hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT songgiwon hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT jungdonghwan hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT ahnchulsoo hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT moondeokbog hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT kimkihun hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT yoonyoungin hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT chohuidong hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT kwonjaehyun hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT chungyongkyu hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT kangsanghyun hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT jungiji hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT choijinuk hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation AT leesunggyu hemashieldvasculargraftisapreferableprostheticgraftformiddlehepaticveinreconstructioninlivingdonorlivertransplantation |